Physical and functional interaction of the p14ARF tumor suppressor with ribosomes

被引:21
|
作者
Rizos, Helen [1 ]
McKenzie, Heather A.
Ayub, Ana Luisa
Woodruff, Sarah
Becker, Therese M.
Scurr, Lyndee L.
Stahl, Joachim
Kefford, Richard F.
机构
[1] Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead Hosp, Westmead, NSW 2145, Australia
[2] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
关键词
D O I
10.1074/jbc.M609405200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alterations in the p14(ARF) tumor suppressor are frequent in many human cancers and are associated with susceptibility to melanoma, pancreatic cancer, and nervous system tumors. In addition to its p53-regulatory functions, p14(ARF) has been shown to influence ribosome biogenesis and to regulate the endoribonuclease B23, but there remains considerable controversy about its nucleolar role. We sought to clarify the activities of p14(ARF) by studying its interaction with ribosomes. We show that p14(ARF) and B23 interact within the nucleolar 60 S preribosomal particle and that this interaction does not require rRNA. In contrast to previous reports, we found that expression of p14(ARF) does not significantly alter ribosome biogenesis but inhibits polysome formation and protein translation in vivo. These results suggest a ribosome- dependent p14(ARF) pathwaythat regulates cellgrowthandthuscomplementsp53-dependent p14(ARF) functions.
引用
收藏
页码:38080 / 38088
页数:9
相关论文
共 50 条
  • [1] Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf
    Luchinat, Enrico
    Chiarella, Sara
    Franceschini, Mimma
    Di Matteo, Adele
    Brunori, Maurizio
    Banci, Lucia
    Federici, Luca
    FEBS JOURNAL, 2018, 285 (05) : 832 - 847
  • [2] Inhibition of p63 transcriptional activity by p14ARF:: Functional and physical link between human ARF tumor suppressor and a member of the p53 family
    Calabrò, V
    Mansueto, G
    Santoro, R
    Gentilella, A
    Pollice, A
    Ghioni, P
    Guerrini, L
    La Mantia, G
    MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (19) : 8529 - 8540
  • [3] Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I
    Ayrault Olivier
    Karayan Lucie
    Riou Jean-François
    Larsen Christian-Jacques
    Séité Paule
    Oncogene, 2003, 22 : 1945 - 1954
  • [4] Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I
    Olivier, A
    Lucie, K
    Jean-François, R
    Christian-Jacques, L
    Paule, S
    ONCOGENE, 2003, 22 (13) : 1945 - 1954
  • [5] Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia
    Müller-Tidow, C
    Metzelder, SK
    Buerger, H
    Packeisen, J
    Ganser, A
    Heil, G
    Kugler, K
    Adigüzel, G
    Schwäble, J
    Steffen, B
    Ludwig, WD
    Heinecke, A
    Büchner, T
    Berdel, WE
    Serve, H
    LEUKEMIA, 2004, 18 (04) : 720 - 726
  • [6] Biophysical characterization of the full-length tumor suppressor protein p14ARF
    不详
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2005, 34 (06): : 721 - 721
  • [7] Global view of nucleolar protein dynamics for P14ARF tumor suppressor signaling
    Yamada, K.
    Ono, M.
    Rocha, S.
    Perkins, N.
    Lamond, A.
    FEBS JOURNAL, 2008, 275 : 143 - 143
  • [8] REGULATION OF P14ARF TUMOR SUPPRESSOR BY HELICOBACTER PYLORI IN GASTRIC EPITHELIAL CELLS
    Horvat, Andela
    Ramatchandirin, Balamurugan
    Noto, Jennifer M.
    El-Rifai, Wael M.
    Peek, Richard M.
    Zaika, Alexander
    GASTROENTEROLOGY, 2018, 154 (06) : S925 - S925
  • [9] Erratum: Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I
    Olivier Ayrault
    Lucie Karayan
    Jean-François Riou
    Christian-Jacques Larsen
    Paule Séité
    Oncogene, 2006, 25 : 2827 - 2827
  • [10] Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia
    C Müller-Tidow
    S K Metzelder
    H Buerger
    J Packeisen
    A Ganser
    G Heil
    K Kügler
    G Adigüzel
    J Schwäble
    B Steffen
    W-D Ludwig
    A Heinecke
    T Büchner
    W E Berdel
    H Serve
    Leukemia, 2004, 18 : 720 - 726